In an attempt to investigate the mechanistic basis of the synergy observed between NVP-AUY922-AG and fludarabine, we examined the effect of both agents, alone and in combination, on the expression of AKT, MAPK, IKKα and IKKβ proteins in CLL cells. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.